CARLSBAD, Calif.--(BUSINESS WIRE)--BriOri BioTech, an emerging pre-clinical stage biotech company focused on developing a pipeline of opiate-free topical pain medications, announces its patent for ...

On Thursday, MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) announced the formulation of Ketamir-2 as a topical treatment for localized neuropathic and inflammatory pain. The advancement expands the ...

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...

Credit: Getty Images. The Food and Drug Administration (FDA) has approved Amzeeq (minocycline; Foamix) topical foam 4% for the treatment of inflammatory lesions of non-nodular moderate to severe acne ...

Critical Clarification: This is ingredient-level research only. NutriDerma Guard as a finished commercial product has not been independently clinically studied in published peer-reviewed trials.

Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...

The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for lidocaine/tetracaine 7%/7% cream (Pliaglis, Nuvo Research Inc and Galderma). Pliaglis was ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.